Assembly Biosciences Inc. (ASMB) NASDAQ
$14.72 - (-)
Market Cap: $81.16M
As of 05/16/24 12:00 AM EDT. Market open.
Assembly Biosciences Inc. (ASMB)
NASDAQ
$14.72
- (-)
Market Cap: $81.16M
As of 05/16/24 12:00 AM EDT. Market open.
Add to Portfolio
assembly biosciences, inc. (nasdaq: asmb) is a public clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis b virus (hbv) infection and novel oral live biotherapeutics for disorders associated with the microbiome. assembly is developing two innovative platform programs: an hbv program advancing a new class of oral therapeutics for the ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$516,667
CEO Compensation (Total)
$4.75M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
110
CEO Compensation (Base)
$516,667
CEO Compensation (Total)
$4.75M
Address
.
PRICE CHART FOR ASSEMBLY BIOSCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$14.72
Days Range
$14.50 - $15.09
52 week range
$7.69 - $20.04
Volume
5,180
Avg. Volume (30 days)
18,342
Market Cap
$81.16M
Dividend Yield
-
P/E
-
Shares Outstanding
5,513,308
Open
-
Previous Close
$14.72
Days Range
$14.50 - $15.09
52 week range
$7.69 - $20.04
Volume
5,180
Avg. Volume (30 days)
18,342
Market Cap
$81.16M
Dividend Yield
-
P/E
-
Shares Outstanding
5,513,308
FINANCIAL STATEMENTS FOR ASSEMBLY BIOSCIENCES INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ASSEMBLY BIOSCIENCES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| White Nicole S | Chief Manufacturing Officer | Apr 30, 2024 | Sale | $12.71 | 1,255 | 15,947 | 13,025 | May 01, 2024, 04:10 PM |
| Okazaki Jason A | CEO and President | Apr 30, 2024 | Sale | $12.71 | 1,569 | 19,937 | 16,423 | May 01, 2024, 04:05 PM |
| McHutchison John G | Director | Apr 01, 2024 | Sale | $13.07 | 1,206 | 15,765 | 21,221 | Apr 02, 2024, 04:25 PM |
| White Nicole S | Chief Manufacturing Officer | Apr 01, 2024 | Sale | $13.07 | 197 | 2,575 | 10,947 | Apr 02, 2024, 04:15 PM |
| Okazaki Jason A | CEO and President | Apr 01, 2024 | Sale | $13.07 | 354 | 4,627 | 13,826 | Apr 02, 2024, 04:05 PM |
| Okazaki Jason A | CEO and President | Mar 27, 2024 | Sale | $12.87 | 392 | 5,045 | 14,180 | Mar 29, 2024, 04:05 PM |
| Schornstein Alexander | 10% Owner | Jan 18, 2024 | Buy | $0.80 | 345,086 | 276,069 | 8,209,372 | Jan 19, 2024, 11:01 AM |
| Schornstein Alexander | 10% Owner | Jan 17, 2024 | Buy | $0.78 | 299,994 | 235,195 | 7,864,286 | Jan 19, 2024, 11:01 AM |
| Schornstein Alexander | 10% Owner | Nov 21, 2023 | Buy | $0.67 | 100,000 | 66,700 | 7,564,292 | Nov 22, 2023, 04:10 PM |
| Schornstein Alexander | 10% Owner | Nov 20, 2023 | Buy | $0.72 | 300,000 | 215,400 | 7,464,292 | Nov 22, 2023, 04:10 PM |
| White Nicole S | Chief Manufacturing Officer | Nov 17, 2023 | Sale | $0.69 | 477 | 329 | 93,774 | Nov 21, 2023, 04:05 PM |
| White Nicole S | Chief Manufacturing Officer | Oct 03, 2023 | Sale | $0.80 | 1,891 | 1,504 | 94,251 | Oct 04, 2023, 04:15 PM |
| Delaney William E IV | Chief Scientific Officer | Oct 03, 2023 | Sale | $0.80 | 1,891 | 1,504 | 150,853 | Oct 04, 2023, 04:10 PM |
| Okazaki Jason A | CEO and President | Oct 03, 2023 | Sale | $0.80 | 2,363 | 1,879 | 174,923 | Oct 04, 2023, 04:05 PM |
| Delaney William E IV | Chief Scientific Officer | Aug 02, 2023 | Sale | $1.09 | 9,461 | 10,293 | 142,744 | Aug 03, 2023, 04:10 PM |
| Okazaki Jason A | CEO and President | Aug 02, 2023 | Sale | $1.09 | 11,827 | 12,867 | 164,786 | Aug 03, 2023, 04:05 PM |
| Bjorkquist Jeanette M | Principal Accounting Officer | Jul 24, 2023 | Sale | $1.07 | 844 | 900 | 26,688 | Jul 25, 2023, 04:30 PM |
| Delaney William E IV | Chief Scientific Officer | May 30, 2023 | Sale | $0.96 | 4,232 | 4,046 | 112,205 | May 31, 2023, 04:05 PM |
| McHutchison John G | Director | May 23, 2023 | Sale | $1.04 | 25,972 | 27,019 | 169,160 | May 24, 2023, 05:15 PM |
| Bjorkquist Jeanette M | Principal Accounting Officer | May 23, 2023 | Sale | $1.04 | 274 | 285 | 27,532 | May 24, 2023, 05:10 PM |
| Delaney William E IV | Chief Scientific Officer | May 23, 2023 | Sale | $1.04 | 6,561 | 6,825 | 116,437 | May 24, 2023, 05:05 PM |
| Okazaki Jason A | CEO and President | May 23, 2023 | Sale | $1.04 | 6,561 | 6,825 | 126,613 | May 24, 2023, 05:00 PM |
| McHutchison John G | Director | Mar 30, 2023 | Sale | $0.82 | 14,883 | 12,252 | 177,632 | Mar 31, 2023, 04:45 PM |
| Bjorkquist Jeanette M | Principal Accounting Officer | Mar 30, 2023 | Sale | $0.82 | 774 | 637 | 23,806 | Mar 31, 2023, 04:40 PM |
| Delaney William E IV | Chief Scientific Officer | Mar 30, 2023 | Sale | $0.82 | 3,421 | 2,816 | 85,498 | Mar 31, 2023, 04:35 PM |
| Okazaki Jason A | CEO and President | Mar 30, 2023 | Sale | $0.82 | 4,247 | 3,496 | 98,174 | Mar 31, 2023, 04:30 PM |
| Okazaki Jason A | CEO and President | Mar 27, 2023 | Sale | $1.02 | 4,693 | 4,785 | 102,421 | Mar 28, 2023, 04:05 PM |
| McHutchison John G | Chief Executive Officer | Aug 08, 2022 | Sale | $2.13 | 12,314 | 26,200 | 192,515 | Aug 10, 2022, 05:00 PM |
| Samar Michael P. | Chief Financial Officer | Jul 25, 2022 | Sale | $2.22 | 2,020 | 4,479 | 77,228 | Jul 26, 2022, 05:00 PM |
| Delaney William E IV | Chief Scientific Officer | May 31, 2022 | Sale | $1.92 | 4,164 | 8,005 | 76,419 | Jun 02, 2022, 05:00 PM |
| Samar Michael P. | Chief Financial Officer | Mar 30, 2022 | Sale | $2.17 | 2,285 | 4,953 | 76,748 | Mar 31, 2022, 04:52 PM |
| Stamm Luisa M | Chief Medical Officer | Mar 30, 2022 | Sale | $2.17 | 1,038 | 2,250 | 40,315 | Mar 31, 2022, 04:48 PM |
| Delaney William E IV | Chief Scientific Officer | Mar 30, 2022 | Sale | $2.17 | 1,038 | 2,250 | 78,083 | Mar 31, 2022, 04:44 PM |
| Okazaki Jason A | Chief Operating Officer | Mar 30, 2022 | Sale | $2.17 | 1,269 | 2,750 | 94,614 | Mar 31, 2022, 04:41 PM |
| McHutchison John G | CEO and President | Mar 30, 2022 | Sale | $2.17 | 4,614 | 10,000 | 204,829 | Mar 31, 2022, 04:36 PM |
| Okazaki Jason A | Chief Operating Officer | Mar 28, 2022 | Sale | $2.24 | 4,617 | 10,363 | 64,633 | Mar 29, 2022, 07:33 PM |
| McHutchison John G | CEO and President | Aug 09, 2021 | Sale | $3.60 | 12,156 | 43,781 | 125,693 | Aug 10, 2021, 05:09 PM |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | Dec 14, 2020 | Sale | $6.15 | 1,297 | 7,983 | 37,364 | Dec 15, 2020, 09:18 PM |
| Stamm Luisa M | Chief Medical Officer | Nov 09, 2020 | Sale | $5.10 | 4,397 | 22,404 | 7,603 | Nov 10, 2020, 07:28 PM |
| McHutchison John G | CEO and President | Aug 07, 2020 | Sale | $21.80 | 12,151 | 264,917 | 138,605 | Aug 10, 2020, 04:34 PM |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | Mar 30, 2020 | Sale | $14.22 | 1,254 | 17,831 | 38,661 | Mar 31, 2020, 04:16 PM |
| Colonno Richard James | EVP & CSO, Virology Ops | Mar 31, 2020 | Sale | $15.04 | 7,812 | 117,524 | 137,009 | Mar 31, 2020, 04:15 PM |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | Dec 13, 2019 | Sale | $21.00 | 1,460 | 30,662 | 22,915 | Dec 16, 2019, 05:21 PM |
| Colonno Richard James | EVP & CSO, Virology Ops | Dec 12, 2019 | Option Exercise | $7.03 | 33,061 | 232,419 | 160,882 | Dec 16, 2019, 05:17 PM |
| Colonno Richard James | EVP & CSO, Virology Ops | Dec 12, 2019 | Sale | $25.00 | 33,061 | 826,578 | 127,821 | Dec 16, 2019, 05:17 PM |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev. | Sep 06, 2018 | Sale | $40.01 | 336 | 13,442 | 613,611 | Sep 07, 2018, 04:44 PM |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev. | Sep 05, 2018 | Sale | $40.09 | 15,204 | 609,547 | 613,947 | Sep 07, 2018, 04:44 PM |
| Small Derek A | CEO and President | Jul 19, 2018 | Buy | $41.48 | 2,400 | 99,551 | 669,291 | Jul 20, 2018, 04:01 PM |
| RINGO WILLIAM R | Director | Jul 02, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Jul 03, 2018, 12:00 AM |
| RINGO WILLIAM R | Director | Jul 02, 2018 | Sale | $38.50 | 1,000 | 38,503 | 19,465 | Jul 03, 2018, 12:00 AM |
| RINGO WILLIAM R | Director | Jun 01, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Jun 01, 2018, 05:54 PM |
| RINGO WILLIAM R | Director | Jun 01, 2018 | Sale | $42.47 | 1,000 | 42,470 | 19,465 | Jun 01, 2018, 05:54 PM |
| RINGO WILLIAM R | Director | May 01, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | May 02, 2018, 04:05 PM |
| RINGO WILLIAM R | Director | May 01, 2018 | Sale | $43.06 | 1,000 | 43,060 | 19,465 | May 02, 2018, 04:05 PM |
| RINGO WILLIAM R | Director | Apr 02, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Apr 02, 2018, 06:07 PM |
| RINGO WILLIAM R | Director | Apr 02, 2018 | Sale | $49.32 | 1,000 | 49,320 | 19,465 | Apr 02, 2018, 06:07 PM |
| RINGO WILLIAM R | Director | Mar 01, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Mar 02, 2018, 12:00 AM |
| RINGO WILLIAM R | Director | Mar 01, 2018 | Sale | $56.37 | 1,000 | 56,370 | 19,465 | Mar 02, 2018, 12:00 AM |
| RINGO WILLIAM R | Director | Feb 01, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Feb 02, 2018, 04:05 PM |
| RINGO WILLIAM R | Director | Feb 01, 2018 | Sale | $46.86 | 1,000 | 46,860 | 19,465 | Feb 02, 2018, 04:05 PM |
| RINGO WILLIAM R | Director | Jan 02, 2018 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Jan 03, 2018, 04:30 PM |
| RINGO WILLIAM R | Director | Jan 02, 2018 | Sale | $45.04 | 1,000 | 45,040 | 19,465 | Jan 03, 2018, 04:30 PM |
| RINGO WILLIAM R | Director | Dec 01, 2017 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Dec 04, 2017, 04:05 PM |
| RINGO WILLIAM R | Director | Dec 01, 2017 | Sale | $49.37 | 1,000 | 49,370 | 19,465 | Dec 04, 2017, 04:05 PM |
| RINGO WILLIAM R | Director | Nov 01, 2017 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Nov 03, 2017, 05:15 PM |
| RINGO WILLIAM R | Director | Nov 01, 2017 | Sale | $29.55 | 1,000 | 29,550 | 19,465 | Nov 03, 2017, 05:15 PM |
| RINGO WILLIAM R | Director | Oct 16, 2017 | Option Exercise | $7.20 | 1,000 | 7,200 | 20,465 | Oct 17, 2017, 06:30 PM |
| RINGO WILLIAM R | Director | Oct 16, 2017 | Sale | $33.70 | 1,000 | 33,700 | 19,465 | Oct 17, 2017, 06:30 PM |
| RINGO WILLIAM R | Director | May 12, 2017 | Sale | $22.00 | 3,461 | 76,142 | 0 | May 16, 2017, 04:31 PM |
| RINGO WILLIAM R | Director | May 10, 2017 | Option Exercise | $23.39 | 1,539 | 35,997 | 23,926 | May 12, 2017, 04:30 PM |
| RINGO WILLIAM R | Director | May 10, 2017 | Option Exercise | $7.20 | 5,000 | 36,000 | 25,465 | May 12, 2017, 04:30 PM |
| Small Derek A | CEO and President | Feb 11, 2016 | Buy | $5.56 | 1,555 | 8,647 | 634,391 | Feb 12, 2016, 04:05 PM |
| Small Derek A | CEO and President | Feb 10, 2016 | Buy | $5.52 | 8,445 | 46,633 | 632,836 | Feb 12, 2016, 04:05 PM |
| ELLISON RUSSELL H | Chief Executive Officer | May 27, 2014 | Buy | $0.92 | 13,000 | 11,960 | 58,000 | May 28, 2014, 05:30 PM |
| ELLISON RUSSELL H | Chief Executive Officer | May 23, 2014 | Buy | $0.91 | 15,000 | 13,603 | 45,000 | May 27, 2014, 09:25 AM |
| ELLISON RUSSELL H | Chief Executive Officer | May 22, 2014 | Buy | $0.90 | 5,000 | 4,500 | 30,000 | May 27, 2014, 09:25 AM |
| BARRETT DAVID JONATHAN | Chief Financial Officer | May 23, 2014 | Buy | $0.88 | 1,000 | 880 | 46,980 | May 27, 2014, 09:12 AM |
| BARRETT DAVID JONATHAN | Chief Financial Officer | May 22, 2014 | Buy | $0.86 | 5,980 | 5,143 | 45,980 | May 27, 2014, 09:12 AM |
| ELLISON RUSSELL H | Chief Executive Officer | May 21, 2014 | Buy | $0.87 | 10,000 | 8,698 | 25,000 | May 22, 2014, 04:36 PM |
| ALTIG ANTHONY E | Director | May 21, 2014 | Option Exercise | $0.88 | 25,000 | 21,900 | 40,000 | May 22, 2014, 04:10 PM |
| BARRETT DAVID JONATHAN | Chief Financial Officer | May 20, 2014 | Buy | $0.88 | 40,000 | 35,200 | 40,000 | May 21, 2014, 09:09 AM |
| ALTIG ANTHONY E | Director | Mar 20, 2013 | Option Exercise | $3.00 | 15,000 | 45,000 | 15,000 | Mar 22, 2013, 07:06 AM |
| ELLISON RUSSELL H | Chief Executive Officer | Feb 05, 2013 | Buy | $2.59 | 5,624 | 14,566 | 15,000 | Feb 06, 2013, 04:08 PM |
| ELLISON RUSSELL H | Chief Executive Officer | Feb 04, 2013 | Buy | $2.52 | 9,376 | 23,628 | 9,376 | Feb 06, 2013, 04:08 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| White Nicole S | Chief Manufacturing Officer | 04/30/2024 | 15,947 |
| Okazaki Jason A | CEO and President | 04/30/2024 | 19,937 |
| McHutchison John G | Director | 04/01/2024 | 15,765 |
| White Nicole S | Chief Manufacturing Officer | 04/01/2024 | 2,575 |
| Okazaki Jason A | CEO and President | 04/01/2024 | 4,627 |
| Okazaki Jason A | CEO and President | 03/27/2024 | 5,045 |
| Schornstein Alexander | 10% Owner | 01/18/2024 | 276,069 |
| Schornstein Alexander | 10% Owner | 01/17/2024 | 235,195 |
| Schornstein Alexander | 10% Owner | 11/21/2023 | 66,700 |
| Schornstein Alexander | 10% Owner | 11/20/2023 | 215,400 |
| White Nicole S | Chief Manufacturing Officer | 11/17/2023 | 329 |
| White Nicole S | Chief Manufacturing Officer | 10/03/2023 | 1,504 |
| Delaney William E IV | Chief Scientific Officer | 10/03/2023 | 1,504 |
| Okazaki Jason A | CEO and President | 10/03/2023 | 1,879 |
| Delaney William E IV | Chief Scientific Officer | 08/02/2023 | 10,293 |
| Okazaki Jason A | CEO and President | 08/02/2023 | 12,867 |
| Bjorkquist Jeanette M | Principal Accounting Officer | 07/24/2023 | 900 |
| Delaney William E IV | Chief Scientific Officer | 05/30/2023 | 4,046 |
| McHutchison John G | Director | 05/23/2023 | 27,019 |
| Bjorkquist Jeanette M | Principal Accounting Officer | 05/23/2023 | 285 |
| Delaney William E IV | Chief Scientific Officer | 05/23/2023 | 6,825 |
| Okazaki Jason A | CEO and President | 05/23/2023 | 6,825 |
| McHutchison John G | Director | 03/30/2023 | 12,252 |
| Bjorkquist Jeanette M | Principal Accounting Officer | 03/30/2023 | 637 |
| Delaney William E IV | Chief Scientific Officer | 03/30/2023 | 2,816 |
| Okazaki Jason A | CEO and President | 03/30/2023 | 3,496 |
| Okazaki Jason A | CEO and President | 03/27/2023 | 4,785 |
| McHutchison John G | Chief Executive Officer | 08/08/2022 | 26,200 |
| Samar Michael P. | Chief Financial Officer | 07/25/2022 | 4,479 |
| Delaney William E IV | Chief Scientific Officer | 05/31/2022 | 8,005 |
| Samar Michael P. | Chief Financial Officer | 03/30/2022 | 4,953 |
| Stamm Luisa M | Chief Medical Officer | 03/30/2022 | 2,250 |
| Delaney William E IV | Chief Scientific Officer | 03/30/2022 | 2,250 |
| Okazaki Jason A | Chief Operating Officer | 03/30/2022 | 2,750 |
| McHutchison John G | CEO and President | 03/30/2022 | 10,000 |
| Okazaki Jason A | Chief Operating Officer | 03/28/2022 | 10,363 |
| McHutchison John G | CEO and President | 08/09/2021 | 43,781 |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | 12/14/2020 | 7,983 |
| Stamm Luisa M | Chief Medical Officer | 11/09/2020 | 22,404 |
| McHutchison John G | CEO and President | 08/07/2020 | 264,917 |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | 03/30/2020 | 17,831 |
| Colonno Richard James | EVP & CSO, Virology Ops | 03/31/2020 | 117,524 |
| Papkoff Jacqueline Sybil | SVP-CSO Microbiome | 12/13/2019 | 30,662 |
| Colonno Richard James | EVP & CSO, Virology Ops | 12/12/2019 | 232,419 |
| Colonno Richard James | EVP & CSO, Virology Ops | 12/12/2019 | 826,578 |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev. | 09/06/2018 | 13,442 |
| Lopatin Uri A | Chief Med. Off., VP Res. Dev. | 09/05/2018 | 609,547 |
| Small Derek A | CEO and President | 07/19/2018 | 99,551 |
| RINGO WILLIAM R | Director | 07/02/2018 | 7,200 |
| RINGO WILLIAM R | Director | 07/02/2018 | 38,503 |
| RINGO WILLIAM R | Director | 06/01/2018 | 7,200 |
| RINGO WILLIAM R | Director | 06/01/2018 | 42,470 |
| RINGO WILLIAM R | Director | 05/01/2018 | 7,200 |
| RINGO WILLIAM R | Director | 05/01/2018 | 43,060 |
| RINGO WILLIAM R | Director | 04/02/2018 | 7,200 |
| RINGO WILLIAM R | Director | 04/02/2018 | 49,320 |
| RINGO WILLIAM R | Director | 03/01/2018 | 7,200 |
| RINGO WILLIAM R | Director | 03/01/2018 | 56,370 |
| RINGO WILLIAM R | Director | 02/01/2018 | 7,200 |
| RINGO WILLIAM R | Director | 02/01/2018 | 46,860 |
| RINGO WILLIAM R | Director | 01/02/2018 | 7,200 |
| RINGO WILLIAM R | Director | 01/02/2018 | 45,040 |
| RINGO WILLIAM R | Director | 12/01/2017 | 7,200 |
| RINGO WILLIAM R | Director | 12/01/2017 | 49,370 |
| RINGO WILLIAM R | Director | 11/01/2017 | 7,200 |
| RINGO WILLIAM R | Director | 11/01/2017 | 29,550 |
| RINGO WILLIAM R | Director | 10/16/2017 | 7,200 |
| RINGO WILLIAM R | Director | 10/16/2017 | 33,700 |
| RINGO WILLIAM R | Director | 05/12/2017 | 76,142 |
| RINGO WILLIAM R | Director | 05/10/2017 | 35,997 |
| RINGO WILLIAM R | Director | 05/10/2017 | 36,000 |
| Small Derek A | CEO and President | 02/11/2016 | 8,647 |
| Small Derek A | CEO and President | 02/10/2016 | 46,633 |
| ELLISON RUSSELL H | Chief Executive Officer | 05/27/2014 | 11,960 |
| ELLISON RUSSELL H | Chief Executive Officer | 05/23/2014 | 13,603 |
| ELLISON RUSSELL H | Chief Executive Officer | 05/22/2014 | 4,500 |
| BARRETT DAVID JONATHAN | Chief Financial Officer | 05/23/2014 | 880 |
| BARRETT DAVID JONATHAN | Chief Financial Officer | 05/22/2014 | 5,143 |
| ELLISON RUSSELL H | Chief Executive Officer | 05/21/2014 | 8,698 |
| ALTIG ANTHONY E | Director | 05/21/2014 | 21,900 |
| BARRETT DAVID JONATHAN | Chief Financial Officer | 05/20/2014 | 35,200 |
| ALTIG ANTHONY E | Director | 03/20/2013 | 45,000 |
| ELLISON RUSSELL H | Chief Executive Officer | 02/05/2013 | 14,566 |
| ELLISON RUSSELL H | Chief Executive Officer | 02/04/2013 | 23,628 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ASSEMBLY BIOSCIENCES INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 947,984 | 0.00002% | Exited | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 612,006 | 0.00005% | Exited | Other |
| RENAISSANCE TECHNOLOGIES LLC | 430,517 | 0.00055% | Exited | Other |
| BLACKROCK INC. | 77,961 | 0.00002% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 52,197 | 0.00006% | New | Other |
| RENAISSANCE TECHNOLOGIES LLC | 39,460 | 0.00083% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR ASSEMBLY BIOSCIENCES INC
STOCK BUYBACKS FOR ASSEMBLY BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
3.04%
1Q
12/31/2022
-88.76%
5Q
09/30/2022
-88.68%
6Q
06/30/2022
-88.65%
7Q
03/31/2022
-88.61%
8Q
12/31/2021
-87.80%
9Q
09/30/2021
-87.97%
10Q
06/30/2021
-87.21%
11Q
03/31/2021
-86.18%
12Q
12/31/2020
-84.66%
13Q
09/30/2020
-84.56%
14Q
06/30/2020
-85.30%
15Q
03/31/2020
-84.37%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ASSEMBLY BIOSCIENCES INC
LOADING...